Literature DB >> 21544138

Translational medicine: to the rescue of the failing heart.

Donald M Bers1, Samantha P Harris.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21544138     DOI： 10.1038/473036a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Cardiac excitation-contraction coupling.

Authors:  Donald M Bers
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Mechanisms and use of calcium-sensitizing agents in the failing heart.

Authors:  David A Kass; R John Solaro
Journal:  Circulation       Date:  2006-01-17       Impact factor: 29.690

Review 3.  The year in heart failure.

Authors:  W H Wilson Tang; Gary S Francis
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

4.  Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.

Authors:  Fady I Malik; James J Hartman; Kathleen A Elias; Bradley P Morgan; Hector Rodriguez; Katjusa Brejc; Robert L Anderson; Sandra H Sueoka; Kenneth H Lee; Jeffrey T Finer; Roman Sakowicz; Ramesh Baliga; David R Cox; Marc Garard; Guillermo Godinez; Raja Kawas; Erica Kraynack; David Lenzi; Pu Ping Lu; Alexander Muci; Congrong Niu; Xiangping Qian; Daniel W Pierce; Maria Pokrovskii; Ion Suehiro; Sheila Sylvester; Todd Tochimoto; Corey Valdez; Wenyue Wang; Tatsuo Katori; David A Kass; You-Tang Shen; Stephen F Vatner; David J Morgans
Journal:  Science       Date:  2011-03-18       Impact factor: 47.728

Review 5.  Rescuing the failing heart by targeted gene transfer.

Authors:  Yoshiaki Kawase; Dennis Ladage; Roger J Hajjar
Journal:  J Am Coll Cardiol       Date:  2011-03-08       Impact factor: 24.094

Review 6.  The ryanodine receptor in cardiac physiology and disease.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Adv Pharmacol       Date:  2010
  6 in total
  6 in total

1.  The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.

Authors:  L Nagy; Á Kovács; B Bódi; E T Pásztor; G Á Fülöp; A Tóth; I Édes; Z Papp
Journal:  Br J Pharmacol       Date:  2015-08-04       Impact factor: 8.739

Review 2.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

3.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

Review 4.  Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series.

Authors:  Sakthivel Sadayappan; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2013-11-07       Impact factor: 3.657

Review 5.  Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.

Authors:  László Nagy; Piero Pollesello; Zoltán Papp
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

6.  Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.

Authors:  Satsuki Yamada; Timothy J Nelson; Garvan C Kane; Almudena Martinez-Fernandez; Ruben J Crespo-Diaz; Yasuhiro Ikeda; Carmen Perez-Terzic; Andre Terzic
Journal:  J Physiol       Date:  2013-04-08       Impact factor: 5.182
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.